Stearoyl-L-carnitine chloride is an endogenous long-chain acylcarnitine and a weak inhibitor of GlyT2, inhibiting glycine transport by 16.8% at concentrations up to 3 μM in Xenopus laevis oocytes; it also inhibits Na+-dependent [3H]carnitine uptake by ~50% in HPCT cells at 500 μM (30 min); its levels are significantly decreased in Alzheimer's disease (AD), mild cognitive impairment (MCI), and subjective memory complaint (SMC), suggesting its potential as a biomarker for these conditions.